Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DeepBiome Therapeutics logo — Harnessing deep learning and synthetic biology to harness th...

DeepBiome Therapeutics

Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome.

Founded 2017 Series Unknown Total: $2.51M Biopharma, Biotechnology +1

General Information

Company Name DeepBiome Therapeutics
Founded Year 2017
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when DeepBiome Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DeepBiome Therapeutics

DeepBiome Therapeutics is a biotechnology firm founded in 2017 and headquartered in Allston, Massachusetts. The company's slogan, "Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome," encapsulates its focus on developing an innovative drug discovery platform. This platform integrates deep learning, microbiome, and synthetic biology technologies, offering pharmaceutical companies the opportunity to explore the therapeutic potential of the microbiome. In July 2019, DeepBiome Therapeutics secured a $2.51M Venture Round investment. With a focus on Biopharma, Biotechnology, and Health and Wellness industries, the company is well-positioned to leverage its expertise in cutting-edge technologies to make significant strides in the field of drug discovery and development.

Taxonomy: drug discovery, deep learning, synthetic biology, microbiome, therapeutic potential, pharmaceutical companies, technology, startup, biotech, Allston, Massachusetts, innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 26 Jul 2019
Seed Round •••••• 2
Investor
•••• •••• 		01 Jan 2019

DeepBiome Therapeutics Alternatives & Competitors

DeepBiome Therapeutics vs
EnteroBiotix
EnteroBiotix

Mastering the microbiome, transforming lives®

Series Unknown
55 employees
Biotechnology, Health Care
DeepBiome Therapeutics vs
MedBiome
MedBiome Canada

Targeting the microbiome to improve human health

1 employees
Biotechnology, Pharmaceutical
DeepBiome Therapeutics vs
Sequential - The Skin Microbiome Testing Co™
Sequential - The Skin Microbiome Testing Co™ United States

The Skin Microbiome Testing Co.™

Seed
18 employees
Health Care, Wellness Beauty
Also compare with: DeepBiome Therapeutics vs Nahibu Nahibu

FAQ About DeepBiome Therapeutics

Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome.
DeepBiome Therapeutics was founded in 2017.
DeepBiome Therapeutics operates in the following industries: Biopharma, Biotechnology, Health and Wellness.
DeepBiome Therapeutics has completed 2 funding rounds, raising a total of $2.51M. The latest funding stage is Series Unknown.
Top alternatives and competitors to DeepBiome Therapeutics include EnteroBiotix, MedBiome, Sequential - The Skin Microbiome Testing Co™, LUCA Biologics, Nahibu. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DeepBiome Therapeutics and EnteroBiotix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DeepBiome Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy